Search Results for: CONTRACT MANUFACTURING Flexibility in an

Articles

November 18, 2013

MARKET BRIEF - Financial Performance Benchmarking & Competitive Landscape Assessment of Leading CROs November 18, 2013

Adam M. Dion, MS, summarizes GlobalData’s recent CRO Benchmark Report and believes the dynamics of pharmaceutical outsourcing and location decisions in emerging markets are changing. Cost reduction is being augmented and will gradually be eclipsed by footprint growth as a major factor shaping decisions, and CROs are realizing that the ability to be on the ground closer to their customers is a key building block to establishing sustainable, long-term relationships with clients.

February 25, 2013

2/27/2012 February 25, 2013

BASF & Bend Research Sign Bioavailability Agreement BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate...
September 10, 2012

9/12/2012 September 10, 2012

Cobra Biologics & Algeta Sign Monoclonal Antibody Agreement Cobra Biologics Ltd and Algeta ASA recently announced a new contract manufacturing...
June 11, 2012

6/13/2012 June 11, 2012

Particle Sciences Expands cGMP Capabilities With Addition of Thin Films Particle Sciences recently announced it has added new coating capabilities...
May 6, 2012

5/9/2012 May 6, 2012

Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
April 29, 2012

5/1/2012 April 29, 2012

3M DDS to Enhance Manufacturing Capabilities 3M Drug Delivery Systems recently announced the expansion of the pressurized metered dose inhaler (pMDI) fill...
December 18, 2011

12/20/2011 December 18, 2011

Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and...
October 20, 2011

10/25/2011 October 20, 2011

Abbott to Separate Into Two Leading Companies Abbott recently announced it plans to separate into two publicly traded companies, one...
July 19, 2011

7/26/2011 July 19, 2011

Daiichi Sankyo Launches Direct Oral Factor Xa Inhibitor Daiichi Sankyo Company, Limited recently announced the launch of LIXIANA (JAN: Edoxaban...